author-photo

Elif Arioglu Oral

National Institutes of Health

13

Papers

1450

Citations

Citation Trend

Filter By

Papers (12) Sort By

Journal Conference Others

Selective Targeting of Angiopoietin-like 3 (ANGPTL3) with Vupanorsen for the Treatment of Patients with Familial Partial Lipodystrophy (FPLD): Results of a Proof-of-Concept Study

2021
Show All
- Source
- Cite
- Save
Citations (0)
Characterizing familial partial lipodystrophy: Baseline data of the BROADEN study

2020
Show All
- Source
- Cite
- Save
Citations (0)
Efficacy and safety of volanesorsen for the treatment of metabolic complications in patients with familial partial lipodystrophy: results of the BROADEN study

2020
Show All
- Source
- Cite
- Save
Citations (1)
Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophy.

2005 Hepatology
Show All
- Source
- Cite
- Save
Citations (199)
Effects of exogenous leptin on satiety and satiation in patients with lipodystrophy and leptin insufficiency.

2004 The Journal of Clinical Endocrinology and Metabolism
Show All
- Source
- Cite
- Save
Citations (96)
Proteinuric Nephropathy in Acquired and Congenital Generalized Lipodystrophy: Baseline Characteristics and Course during Recombinant Leptin Therapy

2004 The Journal of Clinical Endocrinology and Metabolism
Show All
- Source
- Cite
- Save
Citations (86)
Familial lipodystrophy associated with neurodegeneration and congenital cataracts

2002 Neurology
Show All
- Source
- Cite
- Save
Citations (13)
Leptin-replacement therapy for lipodystrophy

2002 The New England Journal of Medicine
Show All
- Source
- Cite
- Save
Citations (1028)
Intensive, Long-Term Plasma Exchange Therapy for Severe Hypertriglyceridemia in Acquired Generalized Lipoatrophy

2002 The Journal of Clinical Endocrinology and Metabolism
Show All
- Source
- Cite
- Save
Citations (27)
Use of leptin for the treatment of human lipoatrophy and method the determining predisposition to such treatment.

2002
Show All
- Source
- Cite
- Save
Citations (0)